Optimized PGT-M Strategy for Patients with No Proband

NAEnrolling by invitationINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
De Novo MutationPreimplantation Genetic TestingWithout Proband
Interventions
DIAGNOSTIC_TEST

Gametes (sperm or second polar bodies, MI eggs) or arrested embryos were reserved for identification of a proband

"1. Targeted deep sequencing for mosaicism detection for patients with suspected gonadal mosaicism, eg. Repeated similar abortion due to the same variant while the couple were tested negative for the variant in the peripheral blood.~2. Ovarian stimulation, embryo culture, biopsy and vitrification as routinely used in the IVF clinical practice.~3. Gametes and arrested embryo preservation by the embryo laboratory during embryo culture.~4. Genetic testing, including multiple displacement amplification for WGA, variant sequencing in WGA products and Infinium Chip protocol for amplified DNA and haplotype analysis"

Trial Locations (1)

200011

Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

ShangHai Ji Ai Genetics & IVF Institute

OTHER